Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Lactobacillus rhamnosus GG and Reduced Fasting Blood Glucose Levels

Doses used in studies

CFU/day: 10 billion (median 10 billion, IQR 10 billion–10 billion) — 1 study

Time to effect

Median: 8 weeks · IQR 8 weeks–8 weeks · Range 8 weeks–8 weeks — Reported in 1 of 1 study

1 of 1 paper

Lactobacillus GG is associated with mucin genes expressions in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
- 2023-03-30
- RCT · n = 34
- European journal of nutrition 62(5)
- - Beyza Eliuz Tipici
  - Ender Coskunpinar
  - Derya Altunkanat
  - Penbe Cagatay
  - Beyhan Omer
  - Sukru Palanduz
  - Ilhan Satman
  - Ferihan Aral
- PubMed: 36997822
- DOI: 10.1007/s00394-023-03139-3
9 Insights on
- Reduced Fasting Blood Glucose Levels
- High evidence
- Rigorous Journal
- Clinical
Fasting blood glucose was significantly decreased in probiotic (p = 0.049) and placebo (p = 0.028), but there was no difference between the groups.
Effect
Neutral
Effect size
Small
Significant
No
Dose
10 × 10^9 Cfu/day